DE2056589A1 - Morpholindenvate - Google Patents

Morpholindenvate

Info

Publication number
DE2056589A1
DE2056589A1 DE19702056589 DE2056589A DE2056589A1 DE 2056589 A1 DE2056589 A1 DE 2056589A1 DE 19702056589 DE19702056589 DE 19702056589 DE 2056589 A DE2056589 A DE 2056589A DE 2056589 A1 DE2056589 A1 DE 2056589A1
Authority
DE
Germany
Prior art keywords
radical
carbon atoms
stands
radicals
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702056589
Other languages
German (de)
English (en)
Inventor
Bernard Joseph Maccles field Cheshire McLoughlin (Großbritannien)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE2056589A1 publication Critical patent/DE2056589A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE19702056589 1969-11-17 1970-11-17 Morpholindenvate Pending DE2056589A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5608669 1969-11-17

Publications (1)

Publication Number Publication Date
DE2056589A1 true DE2056589A1 (de) 1971-05-27

Family

ID=10475688

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702056589 Pending DE2056589A1 (de) 1969-11-17 1970-11-17 Morpholindenvate

Country Status (11)

Country Link
AT (1) AT302341B (ja)
BE (1) BE759013R (ja)
CA (1) CA927831A (ja)
DE (1) DE2056589A1 (ja)
ES (1) ES385627A2 (ja)
FR (1) FR2073375B2 (ja)
GB (1) GB1295447A (ja)
IE (1) IE34714B1 (ja)
NL (1) NL7016833A (ja)
SU (2) SU422159A3 (ja)
ZA (1) ZA707662B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530860A1 (de) * 1975-07-10 1977-01-20 Yoshitomi Pharmaceutical 2-phenoxymethylmorpholin-derivate
DE2901032A1 (de) * 1978-01-20 1979-08-02 Erba Farmitalia Substituierte propanolamin- und morpholin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
WO2005105763A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346340A2 (fr) * 1975-01-29 1977-10-28 Yamanouchi Pharma Co Ltd Derives de l'(indenyloxymethyl)-2-morpholine
GB8824672D0 (en) * 1988-10-21 1988-11-30 Ici Plc Process
GB0219687D0 (en) 2002-08-23 2002-10-02 Lilly Co Eli Benzyl morpholine derivatives
ES2264028T3 (es) 2002-08-23 2006-12-16 Eli Lilly And Company Derivados de bencilmorfolina.
US7384941B2 (en) 2002-08-23 2008-06-10 Eli Lilly And Company 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
FR2880887B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
CA2663984C (en) 2006-10-18 2012-02-21 Pfizer Products Inc. Biaryl ether urea compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530860A1 (de) * 1975-07-10 1977-01-20 Yoshitomi Pharmaceutical 2-phenoxymethylmorpholin-derivate
DE2901032A1 (de) * 1978-01-20 1979-08-02 Erba Farmitalia Substituierte propanolamin- und morpholin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
WO2005105763A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders

Also Published As

Publication number Publication date
FR2073375A2 (ja) 1971-10-01
CA927831A (en) 1973-06-05
GB1295447A (ja) 1972-11-08
ZA707662B (en) 1971-08-25
SU422159A3 (ru) 1974-03-30
NL7016833A (ja) 1971-05-19
SU373945A3 (ja) 1973-03-12
BE759013R (fr) 1971-05-17
AT302341B (de) 1972-10-10
FR2073375B2 (ja) 1974-10-11
ES385627A2 (es) 1973-05-01
IE34714B1 (en) 1975-07-23
IE34714L (en) 1971-05-17

Similar Documents

Publication Publication Date Title
DE2657013C2 (de) 1-(3-Dimethylaminopropyl)-phthalane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0464465B1 (de) Substituierte Aminoalkylbiphenylderivate, antimykotische Präparate damit und Zwischenprodukte für ihre Herstellung
DE2056589A1 (de) Morpholindenvate
DD202715A5 (de) Verfahren zur herstellung von substituierten derivaten des pyridazin
DD215542A5 (de) Verfahren zur herstellung von 4-cyano-pyridazinen
DE2046043A1 (de) Verfahren zur Aufspaltung von DL 5 eckige Klammer auf 3 (tert Butyl ammo) 2 hydroxypropoxy eckige Klammer zu 3,4 dihydro 1(2H) naphthahnon in optische Antipoden
DE1925956A1 (de) Chemische Verfahren und Produkte
DE2406065C2 (de) Neue Isoindolin-1-on-Derivate, deren Säureadditionssalze ihre Herstellung und die Zusammensetzungen, die sie enthalten
DE2507429C2 (de) Aminosäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1915230A1 (de) Hydroxyphenylalkylaminderivate und Verfahren zu deren Herstellung
DE2835536A1 (de) Verfahren zur erzielung eines antioestrogenen effekts bei warmbluetern, hierfuer geeignete zusammensetzungen und verbindungen sowie verfahren zur herstellung dieser verbindungen
DD153550A5 (de) Verfahren zur herstellung von neuer 1,2,4-oxadiazolin-5-on-derivaten
DD139842A5 (de) Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen
CH624659A5 (ja)
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2638849C2 (de) 2-Aminopropionsäure-2-trifluormethylphenyl-1,1-dimethyläthylester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1993020814A1 (de) Immunaktivierende und damit antivirale wirking von 4-[3-(subst.-amino)-2-hydroxypropoxy]-1,2,5-thiadiazolverbindungen
AT256816B (de) Verfahren zur Herstellung von neuen substituierten 1-Phenyl-2-aminoalkanolen und deren Säureadditionssalzen
EP0107208B1 (de) Neue 1,1,2-Triphenyl-but-1-en-Derivate, sowie Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0401798A2 (de) Substituierte Aminoalkylbenzolderivate
DE3706399A1 (de) Mittel mit antidepressiver wirkung
DE2166662B2 (de) Dibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2423835A1 (de) Neue pharmazeutische praeparate
DE2327720A1 (de) Verbesserte alkanolaminderivate
AT281036B (de) Verfahren zur Herstellung von neuen Benz-epinderivaten und ihren Säureadditionssalzen